Indoco Remedies has received approval from US drug regulator for its sterile facility (plant-II) and solid dosage facility (plant –III) located at Verna in Goa. The approval follows the inspection of both these facilities last year by the US Food and Drug Administration.
With this approval, Indoco now has six of its facilities, approved by the US FDA. The six US FDA approved facilities include, three for finished dosages, two for APIs and one for analytical.
“The approval will now facilitate the generic (ANDAs) approvals in the US market and subsequent product launches there. Without doubt, it will also boost the high-margin revenues of Indoco from the remunerative market of US and placing Indoco in the elite league with other International and Indian pharmaceutical companies,” said Suresh G Kare, Chairman, Indoco Remedies.
EP News Bureau – Mumbai
- Advertisement -
